Fibrinogen as a potential biomarker for clinical phenotype in patients with chronic obstructive pulmonary disease

BACKGROUND: Under the Food and Drug Administration’s drug development tool qualification program, fibrinogen is the first biomarker drug development tool used in chronic obstructive pulmonary disease (COPD). However, the correlation between fibrinogen and exacerbations among Korean patients with COP...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Thorac Dis
Main Authors: Kim, Tae Hoon, Oh, Dong Kyu, Oh, Yeon-Mok, Lee, Sei Won, Do Lee, Sang, Lee, Jae Seung
Formato: Artigo
Idioma:Inglês
Publicado em: AME Publishing Company 2018
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6196189/
https://ncbi.nlm.nih.gov/pubmed/30416773
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/jtd.2018.08.52
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados